HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target

Benzinga · 10/17 10:32
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $25 price target.